Drugs that have been investigated to increase so-called “good” cholesterol may not prevent deaths, heart attacks or strokes as many hoped, according to a new analysis.
Due to limitations in existing studies and ongoing experiments involving these and other drugs, researchers not involved with the analysis caution that it’s too early to give up on medications that increase high-density lipoprotein (HDL) cholesterol, however.
